With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020.

Related Article(s):

• COVID-19 Vaccines and Herd Immunity
• The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials
• Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines
• Herd Immunity and Implications for SARS-CoV-2 Control
• Herd Immunity as a Coronavirus Pandemic Strategy